https://www.selleckchem.com/pr....oducts/as1517499.htm
These events promote cytotoxic T cell-mediated clearance of tumor cells and reduce the accumulation of tumor-infiltrating neutrophils. Beneficial immunological features of WEE1 inhibition are further enhanced by the addition of anti-PD-1 therapy. CONCLUSIONS We developed a mouse model system to investigate a novel combinatory approach that illuminates a clinical path hypothesis for combining ICB with DNA damage-inducing therapies in the treatment of LSCC. Copyright ©2020, American Association for Cancer Research.BACKGROUND In ovarian
Like
Comment
Share
